A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
about
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS MethodDevelopment and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates.Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.Application of micellar liquid chromatography for the determination of antitumoral and antiretroviral drugs in plasma.Viral kinetics in semen with different antiretroviral families in treatment-naïve HIV-infected patients: a randomized trial.Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC-MS/MS and its application to a pharmacokinetic study.Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients.Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
P2860
Q28550189-8524E58B-40E6-4214-B028-AA9AEA7AC9C9Q35314702-592A2E71-3460-4E19-933A-A673BEF16AC2Q37538683-17454022-2A40-4142-9357-1C1ADB2C3C13Q38243454-318400FF-CB28-48A1-8FAB-7F2C18EF2B4DQ40225129-28C73E21-DEAA-4F41-B02A-E0FFEE2C8496Q40585903-12C9190A-5AF0-432C-BC90-31DCD24A9F4EQ40735151-728ABFB0-2252-4EC3-9EAB-918878491A24Q49228013-F58C22CA-F1AD-438B-B06C-AA8C07402B7DQ53403180-744ECC6F-E815-46A2-ADF3-FD9E45E495A6Q53806289-D10349D9-9B2A-4E42-A583-DB61AC60D2C8
P2860
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A validated assay by liquid ch ...... rine in HIV positive patients.
@en
A validated assay by liquid ch ...... rine in HIV positive patients.
@nl
type
label
A validated assay by liquid ch ...... rine in HIV positive patients.
@en
A validated assay by liquid ch ...... rine in HIV positive patients.
@nl
prefLabel
A validated assay by liquid ch ...... rine in HIV positive patients.
@en
A validated assay by liquid ch ...... rine in HIV positive patients.
@nl
P2093
P2860
P50
P356
P1476
A validated assay by liquid ch ...... rine in HIV positive patients.
@en
P2093
Amalio Telenti
Andri Rauch
Laurent A Decosterd
Manel Aouri
Thierry Buclin
P2860
P304
P356
10.1002/JMS.3200
P577
2013-05-01T00:00:00Z